About

Shai Assia is Head of Medical Device Development at Clexio Biosciences, a product development leader with more than 15 years of experience across a wide range of responsibilities and organisations.

Mr Assia leads medical device design, development and manufacturing for novel combination products and drug delivery platforms. He holds a BSc in Bio-Medical Engineering from Tel Aviv University (Israel) as well as a MSc in Mechanical Engineering and an MBA from the Massachusetts Institute of Technology (MA, US), where he received the Leaders for Global Operations Fellowship.

Contributions

NASAL

HUMAN FACTORS IN THE ABSENCE OF A FAMILIAR MENTAL MODEL: CHALLENGES & OPPORTUNITIES IN DRUG SELF-ADMINISTRATION

Shai Assia explores the intricate challenge of designing drug-device combination products for self-administration by lay users without medical expertise, focusing on targeted nasal drug delivery devices.

More contributions

EXPERT VIEW

TAKING A DRUG TO FIRST-IN-HUMAN TRIALS IN A BESPOKE DEVICE FOR TARGETED INTRANASAL DELIVERY

Mark Allen, Andrew Fiorini and Shai Assia discuss the need to develop delivery devices early when formulating nasally delivered drugs for systemic and local action, and a method by which the route to clinic can be made easier, faster and cheaper.